LSE creators

Number of items: 28.
Care Policy and Evaluation Centre
  • Arensman, Ella, Leduc, Mallorie, O’Brien, Cliodhna, Corcoran, Paul, Griffin, Eve, Leduc, Caleb, Coppens, Evelien, Tsantila, Fotini, Ross, Victoria & Abdulla, Kahar et al (2023). Implementation and evaluation of a multi-level mental health promotion intervention for the workplace (MENTUPP): study protocol for a cluster randomised controlled trial. Trials, 24(1). https://doi.org/10.1186/s13063-023-07537-0 picture_as_pdf
  • Stoner, Charlotte R, Knapp, Martin, Luyten, Jeroen, Kung, Claryn, Richards, Marcus, Rossor, Martin (2020). The cognitive footprint of medication: a review of cognitive assessments in clinical trials. Journal of Clinical Pharmacy and Therapeutics, 45(4), 874 - 880. https://doi.org/10.1111/jcpt.13151 picture_as_pdf
  • Luyten, Jeroen, Naci, Huseyin, Knapp, Martin (2016). Economic evaluation of mental health interventions: an introduction to cost-utility analysis. Evidence-Based Mental Health, 19, 49-53. https://doi.org/10.1136/eb-2016-102354
    • Health Policy
  • Wouters, Olivier J., Kesselheim, Aaron S., Kuha, Jouni, Luyten, Jeroen (2024). Sales revenues for new therapeutic agents approved by the United States Food and Drug Administration from 1995 to 2014: a retrospective study. Value in Health, 27(10), 1373 - 1381. https://doi.org/10.1016/j.jval.2024.06.015 picture_as_pdf
  • Wouters, Olivier J., McKee, Martin, Luyten, Jeroen (2022). Errors in source data for study of drug development costs. JAMA, 328(11), p. 1110. https://doi.org/10.1001/jama.2022.14317
  • Luyten, Jeroen, McKee, Martin, Wouters, Olivier J. (2020). Wat kost onderzoek en ontwikkeling van een medicijn? Een oproep tot meer transparantie. Nederlands Tijdschrift voor Geneeskunde, 164(34). picture_as_pdf
  • Wouters, Olivier J., McKee, Martin, Luyten, Jeroen (2020). Research and development costs of new drugs: in reply. JAMA, 324(5), p. 518. https://doi.org/10.1001/jama.2020.8651
  • Stoner, Charlotte R, Knapp, Martin, Luyten, Jeroen, Kung, Claryn, Richards, Marcus, Rossor, Martin (2020). The cognitive footprint of medication: a review of cognitive assessments in clinical trials. Journal of Clinical Pharmacy and Therapeutics, 45(4), 874 - 880. https://doi.org/10.1111/jcpt.13151 picture_as_pdf
  • Steel, Jonas, Godderis, Lode, Luyten, Jeroen (2018). Methodological challenges in the economic evaluation of occupational health and safety programmes. International Journal of Environmental Research and Public Health, 15(11). https://doi.org/10.3390/ijerph15112606
    • LSE
  • McDaid, David, Arensman, Ella, Leduc, Mallorie, O’Brien, Cliodhna, Corcoran, Paul, Griffin, Eve, Leduc, Caleb, Coppens, Evelien, Tsantila, Fotini & Ross, Victoria et al (2024). Implementation and evaluation of a multi-level mental health promotion intervention for the workplace (MENTUPP): study protocol for a cluster randomised controlled trial. [Dataset]. figshare. https://doi.org/10.6084/m9.figshare.c.6860296
  • Luyten, Jeroen (2013). Mutual moral obligations in the prevention of infectious diseases. In Denier, Yvonne, Gastmans, Chris, Vandevelde, Antoon (Eds.), Justice, Luck & Responsibility in Health Care: Philosophical Background and Ethical Implications for End-of-Life Care (pp. 85-100). Springer Netherlands. https://doi.org/10.1007/978-94-007-5335-8_5
    • Social Policy
  • Luyten, Jeroen, Beutels, Philippe (2016). ‘Egocentric’ vaccination: the authors reply. Health Affairs, 35(5). https://doi.org/10.1377/hlthaff.2016.0371
  • Luyten, Jeroen, Naci, Huseyin, Knapp, Martin (2016). Economic evaluation of mental health interventions: an introduction to cost-utility analysis. Evidence-Based Mental Health, 19, 49-53. https://doi.org/10.1136/eb-2016-102354
  • Luyten, Jeroen, Beutels, Philippe (2016). The social value of vaccination programs: beyond cost-effectiveness. Health Affairs, 35(2), 212-218. https://doi.org/10.1377/hlthaff.2015.1088
  • Luyten, Jeroen, Kessels, Roselinde, Goos, Peter, Beutels, Philippe (2015). Public preferences for prioritizing preventive and curative health care interventions: a discrete choice experiment. Value in Health, 18(2), 224-233. https://doi.org/10.1016/j.jval.2014.12.007
  • Luyten, Jeroen (2015). Publieke opinie en keuzes in de gezondheidszorg: een reflectie bij het incorporeren van gezondheidsgerelateerde levensstijl en patiëntenleeftijd in terugbetalingsbeslissingen. Belgisch Tijdschrift voor Sociale Zekerheid, 50(3), 517-534.
  • Luyten, Jeroen, Ogunjimi, Benson, Beutels, Philippe (2014). Varicella-zoster virus vaccination under the exogenous boosting hypothesis: two ethical perspectives. Vaccine, 32(52), 7175-7178. https://doi.org/10.1016/j.vaccine.2014.10.015
  • Luyten, Jeroen, Desmet, Pieter, Dorgali, Veronica, Hens, Niel, Beutels, Philippe (2014). Kicking against the pricks: vaccine sceptics have a different social orientation. European Journal of Public Health, 24(2), 310-314. https://doi.org/10.1093/eurpub/ckt080
  • Luyten, Jeroen, Engelen, Bart, Beutels, Philippe (2014). The sexual ethics of HPV vaccination for boys. HEC Forum, 26(1), 27-42. https://doi.org/10.1007/s10730-013-9219-z
  • Luyten, Jeroen (2014). Inentingsethiek. Medi-sfeer : tijdschrift uitgegeven voor huisartsen en specialisten, 439, 22-26.
  • Luyten, Jeroen (2014). Seks en de morele plicht tot HPV-vaccinatie. Andrologic, 10(1), 3-4.
  • Luyten, Jeroen, Dorgali, Veronica, Hens, Niel, Beutels, Philippe (2013). Public preferences over efficiency, equity and autonomy in vaccination policy: an empirical study. Social Science & Medicine, 77, 84-89. https://doi.org/10.1016/j.socscimed.2012.11.009
  • Luyten, Jeroen (2013). Seks en de morele plicht tot HPV-vaccinatie. Gunaïkeia: Nederlandse uitgave, 19(1), 30-31.
  • Luyten, Jeroen (2013). Seks en de morele plicht tot HPV-vaccinatie. Medi-sfeer : tijdschrift uitgegeven voor huisartsen en specialisten, 431, 27-28.
  • Luyten, Jeroen (2013). Seks en de morele plicht tot HPV-vaccinatie. Onco-hemato: multidisciplinair tijdschrift voor oncologie, 7(7), 3-4.
  • Luyten, Jeroen, Van de Sande, Stefaan, De Schrijver, Koen, Van Damme, Pierre, Beutels, Philippe (2012). Cost-effectiveness of hepatitis A vaccination for adults in Belgium. Vaccine, 30(42), 6070-6080. https://doi.org/10.1016/j.vaccine.2012.07.049
  • Luyten, Jeroen, Vandevelde, Antoon, Van Damme, Pierre, Beutels, Philippe (2011). Vaccination policy and ethical challenges posed by herd immunity, suboptimal uptake and subgroup targeting. Public Health Ethics, 4(3), 280-291. https://doi.org/10.1093/phe/phr032
  • Luyten, Jeroen, Marais, Christiaan, Hens, Niel, De Schrijver, Koen, Beutels, Philippe (2011). Imputing QALYs from single time point health state descriptions on the EQ-5D and the SF-6D: a comparison of methods for hepatitis A patients. Value in Health, 14(2), 282-290. https://doi.org/10.1016/j.jval.2010.10.004
  • Luyten, Jeroen, Beutels, Philippe (2009). Costing infectious disease outbreaks for economic evaluation. PharmacoEconomics, 27(5), 379-389. https://doi.org/10.2165/00019053-200927050-00003
  • Beutels, Philippe, Luyten, Jeroen, Lejeune, Olivier, Hens, Niel, Bilcke, Joke, De Schrijver, Koen, Van de Sande, Stefaan, Van Herck, Koen, Van Damme, Pierre (2008). Evaluatie van universele en doelgroep hepatitis A vaccinatie opties in België = Evaluation of universal and targeted hepatitis A vaccination programs in Belgium. (KCE reports 98A (D/2008/10.273/88)). Federaal Kenniscentrum voor de Gezondheidszorg (KCE).
    • Statistics
  • Wouters, Olivier J., Kesselheim, Aaron S., Kuha, Jouni, Luyten, Jeroen (2024). Sales revenues for new therapeutic agents approved by the United States Food and Drug Administration from 1995 to 2014: a retrospective study. Value in Health, 27(10), 1373 - 1381. https://doi.org/10.1016/j.jval.2024.06.015 picture_as_pdf